Suchergebnisse - "Benner, Axel"

PubPharm (642)

1

Statistical plasmode simulations-Potentials, challenges and recommendations

enthalten in: Statistics in medicine | 2024

von Schreck, N. | Slynko, A. | Saadati, M. | +1

2

Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation : The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause

enthalten in: Transplantation and cellular therapy | 2024

von Sala, E. | Neagoie, A. | Lewerenz, J. | +6

3

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia : a report of 7235 patients from seven cohorts

enthalten in: Leukemia | 2024

von Appelbaum, J. | Wei, A. | Mandrekar, S. | +26

4

Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation : a prospective study

enthalten in: Journal for immunotherapy of cancer | 2024

von Penack, O. | Luft, T. | Peczynski, C. | +19

5

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The lancet / Haematology | February 2024

von Mai, E. | Goldschmidt, H. | Miah, K. | +32

6

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia

enthalten in: Haematologica | 2024

von Shahswar, R. | Beutel, G. | Gabdoulline, R. | +17

7

Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years : Results from the First Screening Round of the PROBASE Trial

enthalten in: European urology | 2024

von Boschheidgen, M. | Albers, P. | Schlemmer, H. | +24

8

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Leypoldt, L. | Tichy, D. | Besemer, B. | +24

9

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Mai, E. | Goldschmid, H. | Miah, K. | +74

ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740

10

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Salwender, H. | Weinhold, N. | Benner, A. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[65]